Indegene Share Price Target 2024 To 2030 – Shareholding Pattern For Indegene Share Price

Indegene Share Price Target 2024 To 2030 - Shareholding Pattern For Indegene Share Price

Indegene is a global company that delivers advanced solutions and services to the pharmaceutical, biotechnology, and healthcare sectors. With its strong foundation in medical expertise, extensive technological capabilities, and domain knowledge, Indegene is positioned for significant growth in the coming years.

This comprehensive analysis will project Indegene’s share prices from 2024 to 2030, incorporating essential financial metrics and trends that influence the company’s market performance. 

Indegene Share Price Current Market Overview

  • Market Cap: 16.44kcr
  • Open: 677.00
  • High: 720.00
  • Low: 676.10
  • Current Share Price: 689.00
  • P/E Ratio: N/A
  • Dividend Yield: N/A
  • 52 Week High: 720.90
  • 52 Week Low: ₹470.10

Indegene Share Price Current Graph 
Indegene Share Price Current Graph 

Indegene Share Price Target Tomorrow From 2024 To 2030

In the table below, you will find Indegene’s projected monthly percentage expenses from 2024 to 2030. The projections are based on marketplace dispositions, business business performance, and financial indicators.

Year  Share Price Target 
2024 674.50
2025 733.20
2026 883.20
2027 990.45
2028 1089.78
2029 1192.45
2030 1278.15

Shareholding Pattern For Indegene Share Price

  • Retail And Others: 92.37%
  • Foreign Institutions: 3.79%
  • Mutual Funds: 2.31%
  • Other Domestic Institutions: 1.53%

Indegene Share Price Annual Income Statement

The given chart shows the comparison between revenue and net income.

Indegene Share Price Annual Income Statement

Here is detailed information regarding the Indegene annual income statement.

Particulars Info 2024 Y/Y Change
Revenue 6.77B 11.36% (+)
Operating Expenses 5.68B 6.93% (+)
Net Income 877.00M 28.22% (+)
Net Profit Margin 12.96M 15.10% (+)
Earning Per Share N/A N/A

Key Factors For Indegene Share Price

  • Innovation in virtual health and telemedicine.
  • Strategic partnerships and collaborations.
  • Investment in human capital and talent improvement.
  • Financial Performance and Key Metrics

Leave a Comment

Your email address will not be published. Required fields are marked *